A New Paradigm of Cardiohematological Monitoring in Patients With Chronic Myeloid Leukemia Taking Tyrosine Kinase Inhibitors. UJC 2022, 29 (1-2), 72-86. https://doi.org/10.31928/1608-635X-2022.1-2.7286.